Table I.
Patient demographics for all FF assessed for PCs.
| All patients (n = 261) | Patients with PCs in FF (n = 17) | Patients who were negative for all measured PCs in FF (n = 244) | Significance | |
|---|---|---|---|---|
| Age (years) | 32.3 ± 0.4 (21–45) | 28.3 ± 1.3 (21–40) | 32.7 ± 0.4 (22–45) | P = 0.006 |
| BMI (kg/m2) | 24.4 ± 0.3 (14.9–44.6) | 24.9 ± 1.4 (16.8–38.4) | 24.4 ± 0.3 (14.9–44.6) | NS |
| AMH (pmol/L) | 29.6 ± 1.5 (1.2–127.8) | 27.5 ± 5.2 (4.0–94.2) | 29.7 ± 1.7 (1.2–127.8) | NS |
| Day 3 FSH (IU) | 6.4 ± 0.1 (0.2–12.2) | 5.9 ± 0.6 (0.2–8.4) | 6.4 ± 0.2 (0.5–12.2) | NS |
| Peak oestradiol (pmol/L) | 14418.5 ± 530.9 (2363–43 301) | 13595.8 ± 1912.4 (5460–28 472) | 14478.3 ± 612.3 (2363–43 301) | NS |
FF, follicular fluid. NS, not significant. PC, phytocannabinoid.